Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Menu
Sign in
Sign in

European Commission Gives Nod to Astellas and Seagen’s Padcev for Urothelial Cancer

European Commission Gives Nod to Astellas and Seagen’s Padcev for Urothelial Cancer

The European Commission has approved Astellas Pharma’s and Seagen’s antibody drug conjugate, Padcev (enfortumab vedotin), for the treatment of adults with locally advanced or metastatic urothelial cancer who previously received a platinum-containing chemotherapy and a programmed death ligand-1 (PD-L1) or programmed death-1 (PD-1) inhibitor.

The approval was based on the results of a phase 3 trial in 608 participants. Those given the drug showed a significant overall survival benefit compared with participants who just received chemotherapy. The median overall survival in treated patients was 12.9 months compared with nine months for those who received chemotherapy alone.

Padcev received an accelerated approval from the FDA in December 2019 for the same indication. The agency granted full approval in July 2021.

Enfortumab vedotin, sold under the brand name Padcev, is an antibody-drug conjugate used for the treatment of urothelial cancer. It is a nectin-4-directed antibody and microtubule inhibitor conjugate. Enfortumab refers to the monoclonal antibody part, and vedotin refers to the payload drug (MMAE) and the linker.

April 20, 2022

https://www.fdanews.com/


0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company

We use "cookies*  to ensure the functionality of our website, recognise your browser or device, learn more about your interests, and provide you with essential features and services and for additional purposes, including:

Recognising you when you sign-in to use our services. This allows us to provide you with product recommendations, display personalised content, and provide other customised features and services.
Keeping track of your specified preferences. You may set your preferences through Your Account..
Keeping track of items stored in your shopping basket and personal cabinet.
Conducting research and diagnostics to improve ChemDiv’s content, products, and services.
Delivering content, including ads, relevant to your interests on ChemDiv’s site
Reporting. This allows us to measure and analyse the performance of our services.

By  cookies you give consent to the processing of your personal data, including transfer to third parties. Further information can be found in our privacy policy.

Accept all cookies